Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InflaRx (IFRX) Shares Outstanding (Weighted Average) (2022 - 2025)

Historic Shares Outstanding (Weighted Average) for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to $9.5 million.

  • InflaRx's Shares Outstanding (Weighted Average) fell 8530.31% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year decrease of 8530.31%. This contributed to the annual value of $7.7 million for FY2024, which is 8695.93% down from last year.
  • InflaRx's Shares Outstanding (Weighted Average) amounted to $9.5 million in Q3 2025, which was down 8530.31% from $396.19 recorded in Q2 2025.
  • Over the past 5 years, InflaRx's Shares Outstanding (Weighted Average) peaked at $66.6 million during Q1 2025, and registered a low of $330.79 during Q2 2022.
  • In the last 4 years, InflaRx's Shares Outstanding (Weighted Average) had a median value of $45.1 million in 2022 and averaged $34.9 million.
  • In the last 5 years, InflaRx's Shares Outstanding (Weighted Average) soared by 4381.97% in 2023 and then plummeted by 8712.49% in 2024.
  • Quarter analysis of 4 years shows InflaRx's Shares Outstanding (Weighted Average) stood at $45.1 million in 2022, then soared by 31.06% to $59.1 million in 2023, then crashed by 87.12% to $7.6 million in 2024, then rose by 24.88% to $9.5 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $9.5 million in Q3 2025, compared to $396.19 in Q2 2025 and $66.6 million in Q1 2025.